For decades, multinational pharmaceutical companies and Indian drugmakers worked in ways that supported each other: MNCs brought innovation and brands, while Indian companies built scale through generics and cost efficiency. There was an important overlap - generic drugs - but this is shrinking fast. And the consequences are reshaping India's gigantic pharmaceutical market.
In a region increasingly shaped by competition and coercion, such collaboration strengthens security without confrontation, builds capacity without dependency and promotes order without domination, points out Dr Kumar.
Restoring weighted tax deductions and adopting a petty patents regime can foster firm-level innovative activity critical for competitiveness, points out Nagesh Kumar.
'Our problem is not a budget deficit but a trust deficit. We need to trust our institutions and industries to innovate and lead. That is the way forward for India.'
India and the European Union are set to announce on January 27 the conclusion of negotiations and finalisation of a free trade agreement, which is aimed at boosting economic ties between the two regions amid disruptions in global trade due to US tariffs, an official said.
Prime Minister Narendra Modi on Tuesday announced the signing of the India-EU Free Trade Agreement (FTA), saying it accounts for 25 per cent of global GDP and one-third of global trade.
The US on Tuesday again placed India on its 'priority watch list' stating that New Delhi remains one of the world's most challenging major economies with respect to protection and enforcement of intellectual property (IP) rights.
'The tools of warfare are changing. The MoD must deepen its engagement with technology thinkers that can present compelling visions of where warfare may be heading.'
The Bill is likely to pave the way for amending two existing legislations -- the Atomic Energy Act 1962, and the Civil Liability for Nuclear Damage Act 2010.
They are venturing into allied businesses, which range from starting talent management agencies to music labels to tap into every possible monetisable opportunity to appeal to investors.
Nyrraa Banerji's reason for staying away from Bollywood for a while: 'In Bollywood, there was a phase where all the movies were getting very bold. Physical intimacy was the criteria at that time for films. I didn't want to be part of that.'
'Solutions developed in India are being commercialised and offered globally because we're executing at scale, creating new markets and revenue streams.'
'AdFalciVax may offer advantages such as broader protection and a lower risk of immune evasion compared to existing single-stage malaria vaccines.'
Only firms that have scale in content and a technology engine that drives its discovery and monetisation can compete,' explains Vanita Kohli Khandekar.
India remains one of the largest and fastest-growing markets for SAP, and the scale of products being built in the country is bigger compared to other geographies, Manish Prasad, president and managing director of SAP India, said. "The beauty of India is scale, size, and agility.
A rally marking the 41st anniversary of the Bhopal gas tragedy was disrupted by a controversy over an effigy allegedly depicting an RSS 'sevak,' leading to an FIR against organizers.
Delhi high court ruling on numbers as trademarks could be a trendsetter.
Ola Electric has denied media reports suggesting its involvement in a leak of proprietary pouch cell technology (tech) from South Korea's LG Energy Solution, calling the allegations "baseless". The company said it has no commercial or research interest in the older pouch cell format cited in the reports, emphasising that its new 4680 Bharat Cell - based on advanced dry-electrode cylindrical tech - is already in commercial production.
If the 'Captain Cool' trademark goes through, it could trigger a wave of similar attempts by celebrities to trademark nicknames given to them by fans.
Amid US-China trade tensions and economic vulnerabilities, India must seize the 'China +1' opportunity, deepen reforms, secure FTAs, and globalise its firms for long-term growth, suggests Ajay Shah.
India will publish its revised Nationally Determined Contribution (NDC) for the 2035 period by December, Environment Minister Bhupender Yadav said on Monday, while urging developed nations to achieve net zero targets ahead of their current timelines.
It said Sadhguru has acquired uniqueness pertaining to his personality qua his voice, name, signature, image, likeness, vocal, articulation style and his unique attire, looks or appearance.
Dismissing allegations that Indian phacosrmaceutical companies copy products of Swiss firms, Commerce and Industry Minister Piyush Goyal on Tuesday said it is a long-standing myth and India respects intellectual property rights and never steals technology from others. He said that Swiss pharmaceutical companies have not shown even a single instance that Indian companies have illegally copied any of their trademarks or patents or copyrighted technology.
According to official records, Kishor is enrolled as a voter in West Bengal at 121, Kalighat Road, the address of the Trinamool Congress headquarters in Kolkata's Bhabanipur assembly constituency, which is Chief Minister and TMC chief Mamata Banerjee's seat, he said.
'It's heartening to see that the festive energy is being driven not only by star-led blockbusters but also by fresh, content-rich films.'
Astrologer Chirag Daruwalla, who is following in the footsteps of his famed astrologer father, the late Bejan Daruwalla, helps you navigate the Naya Saal.
Commerce and Industry Minister Piyush Goyal on Tuesday said India and the 27-nation EU bloc are "really very near" to concluding talks for the proposed free trade agreement, with only a few issues left to be resolved.
'When global politics has some intervention on the core software one uses, and if you are cut off from your own data in critical workflows, sovereignty is no longer optional. It becomes a necessity.'
India and the UK will sign a free trade agreement on Thursday in London that will allow export of labour-intensive products such as leather, footwear and clothing at concessional rates, while making imports of whisky and cars from Britain cheaper. The pact also helps double trade between the two economies to $120 billion by 2030.
Who else will take on the might of Microsoft, Google, and Amazon if not the Adanis, Ambanis, Birlas, or Tatas?, asks R Jagannathan.
India has not accepted the demand of the UK for inclusion of a 'data exclusivity' provision in the free trade agreement, announced on May 6, in a bid to protect the interests of the domestic generic drugs industry, an official said. During the negotiations, the UK had asked to include this provision in the trade pact.
'Even if tariffs are reduced, non-tariff may still remain a challenge.'
'A rigid or overly broad interpretation could lead to a chilling effect on investments and growth in sectors traditionally driven by private initiative.' 'Entrepreneurs may fear that their assets could be arbitrarily appropriated by the State under the guise of serving the 'common good' without sufficient legal safeguards.' 'The judgment thus supports a more nuanced view, one that balances individual property rights with public welfare objectives.'
These are 'hidden champions' of strategic research and innovation. They are worthy of emulation within Indian industry, and maybe even a Padma!, notes R Gopalakrishnan.
What has surprised the industry is that the Bill has been tabled without any consultation. Critics warn the ban on real-money gaming could fuel black markets, endanger 200,000 jobs and billions in tax revenue.
India maintains "high" import duties on a wide range of American goods such as agricultural items, drug formulations, and alcoholic beverages, besides imposing non-tariif barriers, a US report has said. A day before announcing reciprocal tariffs, the US Trade Representative (USTR) released the 2025 National Trade Estimate (NTE) Report on March 31.
'We don't make films for profit and that's exactly why profit follows.'
'The LVM3 rocket will orbit one Block 2 BlueBird satellite in Low Earth Orbit.'
US President Donald Trump's plan to sign an executive order to cut prescription drug prices by 30-80 per cent could lead to a global price adjustment with pharma firms pushing lower-cost countries like India to raise prices, according to the economic think tank GTRI. The US move could push prices in lower-cost countries like India as manufacturers would seek to recover losses and R&D costs from these nations.
'This case is not a good example of intellectual property strategy for either sector.'
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances